"We are delighted to have the continued support of Square 1 Bank," stated Steven St. Peter, M.D., President and Chief Executive Officer of Aratana Therapeutics. "We're grateful Square 1 has remained a supporter of Aratana since its inception and are eager to extend our relationship as we advance our programs." Scott Foote, senior vice president in Square 1 Bank's Life Sciences practice, added, "We are pleased to provide Aratana with the financing solutions it needs to support future developments in the animal health market, and we look forward to the company's future success." About Aratana Therapeutics Aratana Therapeutics is a biopharmaceutical company positioned to deliver high quality new medicines that address significant therapeutic needs for cats and dogs (companion animals).